Skip to content

Clinical trials

Phase 2 Lymphoma, Large B-Cell, Diffuse trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 2 Country / region: Israel Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20122
20141
20161
20171
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Cellectar Biosciences, Inc.1
CureTech Ltd1
Genmab1
Karyopharm Therapeutics Inc1
MedImmune LLC1
Meirav Kedmi MD1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse9
Recurrence5
Lymphoma, Non-Hodgkin4
Neoplasms3
Lymphoma2
Blood Protein Disorders1
Hematologic Diseases1
Immunoproliferative Disorders1
Leukemia, Hairy Cell1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.